← Back
Data updated: Mar 10, 2026
NAVINTA LLC
ImmunologyInfectious DiseaseNeurology
NAVINTA LLC is a generic drug manufacturer focused on Immunology, Infectious Disease, Neurology. Key products include CARMUSTINE.
2008
Since
21
Drugs
-
Trials
82
Approved (2yr)
Recent Activity
SODIUM PHENYLBUTYRATE 2026-02-17
NICARDIPINE HYDROCHLORIDE 2025-12-18
Manufacturing (CMC)
DIAZEPAM 2025-11-14
MARAVIROC 2025-11-04
NICARDIPINE HYDROCHLORIDE 2025-10-28
SEVELAMER CARBONATE 2025-10-27
NICARDIPINE HYDROCHLORIDE 2025-08-20
DIAZEPAM 2025-08-08
Labeling
DIAZEPAM 2025-08-08
Labeling
DIAZEPAM 2025-08-08
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 29%
2 drugs
Infectious Disease 29%
2 drugs
Neurology 14%
1 drugs
Cardiovascular 14%
1 drugs
Oncology 14%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Merck big-pharma
Oncology, Infectious Disease, Cardiovascular, Immunology
AbbVie big-pharma
Immunology, Oncology, Neurology, Infectious Disease
Johnson & Johnson big-pharma
Oncology, Immunology, Infectious Disease, Cardiovascular
GSK big-pharma
Infectious Disease, Oncology, Immunology, Neurology
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Infectious Disease, Neurology
Active (13)
Discontinued (7)
Company Info
- First Approval
- 2008-03-06
- Latest
- 2026-02-17
- Applications
- 23